Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories geographic Revenue — Japan ($M) ($M)
Postgres DB segment_values + Form 10-K Geographic Footnote
Latest, FY2025
1,475
Period ended Dec 31, 2025
Change on a year earlier
+2.4%
1,441 in FY2024
History
16 years
Since FY2010
Sources
14
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Geographic Revenue — Japan ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,475 | +2.4% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 1,441 | -4.8% | Form 10-K (filed 2025-02-21) ↗ |
| FY2023 | Dec 31, 2023 | 1,513 | -21.7% | Form 10-K (filed 2024-02-16) ↗ |
| FY2022 | Dec 31, 2022 | 1,932 | +14.0% | Form 10-K (filed 2023-02-17) ↗ |
| FY2021 | Dec 31, 2021 | 1,695 | +22.3% | Form 10-K (filed 2022-02-18) ↗ |
| FY2020 | Dec 31, 2020 | 1,386 | -3.4% | Form 10-K (filed 2021-02-19) ↗ |
| FY2019 | Dec 31, 2019 | 1,435 | +8.2% | Form 10-K (filed 2020-02-21) ↗ |
| FY2018 | Dec 31, 2018 | 1,326 | +5.7% | Form 10-K (filed 2019-02-22) ↗ |
| FY2017 | Dec 31, 2017 | 1,255 | +35.8% | Form 10-K (filed 2018-02-16) ↗ |
| FY2016 | Dec 31, 2016 | 924 | +3.2% | Form 10-K (filed 2017-02-17) ↗ |
| FY2015 | Dec 31, 2015 | 895 | -7.5% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 968 | -7.1% | Form 10-K (filed 2015-02-27) ↗ |
| FY2013 | Dec 31, 2013 | 1,042 | -14.7% | Form 10-K (filed 2015-02-27) ↗ |
| FY2012 | Dec 31, 2012 | 1,221 | -29.3% | Form 10-K (filed 2015-02-27) ↗ |
| FY2011 | Dec 31, 2011 | 1,726 | -14.8% | Form 10-K (filed 2014-02-21) ↗ |
| FY2010 | Dec 31, 2010 | 2,025 | – | Form 10-K (filed 2013-02-15) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Geographic Revenue — Japan ($M) ($M), annual FY2010–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-geo-jp
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.